The following is a list of what is included in the item above. Click the test(s) below to view what biomarkers are measured along with an explanation of what the biomarker is measuring.
Also known as: EpsteinBarr Virus DNA Quantitative RealTime PCR
The Epstein-Barr Virus DNA, Quantitative, Real-Time PCR test contains 1 test with 3 biomarkers.
Brief Description: The Epstein-Barr Virus (EBV) DNA Quantitative Real-Time PCR test is an advanced laboratory technique used to detect and measure the amount of EBV DNA in a patient's blood or other body fluids. Real-Time PCR, also known as qPCR, quantifies the DNA by amplifying the target genetic material and simultaneously measuring the amount of amplification. This provides both a qualitative (presence or absence) and quantitative (how much) result for the targeted DNA.
Collection Method: Blood Draw
Specimen Type: Whole Blood
Test Preparation: No preparation required
The test is commonly ordered in the following situations:
Suspected EBV Infection: Especially when classical serological tests (antibody tests) are inconclusive or when a more detailed view of the viral load is necessary.
Monitoring Treatment: In cases where patients with EBV-associated diseases are undergoing antiviral or other targeted therapies, the test can be used to monitor the effectiveness of the treatment by measuring changes in viral load.
Post-Transplant Monitoring: Patients who have undergone organ transplantation are at a higher risk of developing EBV-related complications due to immunosuppressive medications. Monitoring EBV DNA levels can help in early detection and management.
This test detects and quantifies the presence of Epstein-Barr Virus DNA. High levels of EBV DNA in the blood can indicate an active infection or a reactivation of a latent EBV infection.
When a Quantitative EBV DNA PCR test is ordered, it's often part of a broader evaluation of EBV-related diseases and immune status. Here are some tests commonly ordered alongside it:
Complete Blood Count (CBC) with Differential:
EBV Serology (VCA-IgM, VCA-IgG, EBNA):
Immunoglobulins (IgG, IgM, IgA):
HLA Typing (in transplant patients):
These tests, when ordered alongside a Quantitative Epstein-Barr Virus DNA PCR test, provide a comprehensive assessment of EBV infection and its impact, particularly in immunocompromised patients or in cases where complications are suspected. They are crucial for diagnosing EBV infection, monitoring disease progression, and guiding treatment decisions. The specific combination of tests will depend on the individual’s symptoms, clinical presentation, and risk factors.
This test can be crucial in diagnosing and managing:
Infectious Mononucleosis: Caused by the EBV.
EBV-associated cancers: Like Burkitt's lymphoma, nasopharyngeal carcinoma, and certain types of Hodgkin's and non-Hodgkin's lymphomas.
Post-transplant lymphoproliferative disorder: A complication in transplant recipients associated with EBV.
Healthcare providers use the results to:
Diagnose Active Infections: Especially when symptoms are consistent with EBV infection and other tests are inconclusive.
Monitor Disease Progression: Tracking changes in the viral load can indicate the progression or regression of diseases like infectious mononucleosis or EBV-associated cancers.
Guide Treatment Decisions: Especially in post-transplant patients or those with EBV-associated cancers, where levels of EBV DNA can influence treatment strategies and choices.
It's essential to interpret the results in the context of the clinical scenario and consider other diagnostic information.
Why is the Epstein-Barr Virus DNA Quantitative Real-Time PCR test performed?
The Epstein-Barr Virus (EBV) DNA Quantitative Real-Time PCR test is used to detect and measure the amount of EBV DNA in a sample. This helps in monitoring the viral load in patients, especially post-transplant patients, to ensure early detection of EBV-related post-transplant lymphoproliferative disorders.
When is the Epstein-Barr Virus DNA Quantitative Real-Time PCR test recommended?
The test is often recommended for patients who have undergone organ transplants and are at risk of developing complications due to EBV. It is also useful for monitoring the effectiveness of antiviral therapy in patients with chronic EBV infections.
What does a positive result mean in the Epstein-Barr Virus DNA Quantitative Real-Time PCR test?
A positive result indicates the presence of EBV DNA in the sample, suggesting an active or latent infection. Quantitative results provide information on the viral load, with higher numbers indicating a higher concentration of the virus.
How is the viral load from the Epstein-Barr Virus DNA Quantitative Real-Time PCR test used in clinical management?
The viral load helps physicians assess the severity of an EBV infection and monitor the effectiveness of treatment. A decreasing viral load typically indicates successful treatment, while an increasing or persistently high viral load may signal the need for a change in therapeutic approach.
What should be done if the Epstein-Barr Virus DNA Quantitative Real-Time PCR test shows a high viral load?
A high viral load requires medical attention. Depending on the patient's clinical scenario, the physician might adjust the immunosuppressive regimen, initiate antiviral therapy, or take other therapeutic measures. Regular monitoring will also be essential.
How frequently should the Epstein-Barr Virus DNA Quantitative Real-Time PCR test be repeated?
The frequency depends on the clinical context. In post-transplant patients or those on antiviral therapy, the test might be repeated more often to closely monitor the viral load. In other scenarios, the frequency is determined by the physician based on the patient's health status and risk factors.
How does the Epstein-Barr Virus DNA Quantitative Real-Time PCR test work?
The test uses real-time PCR technology to amplify and simultaneously quantify a targeted DNA molecule in the sample. Specifically for EBV, it targets a particular segment of the EBV genome, enabling accurate detection and quantification of the virus.
Can other infections or conditions affect the results of the Epstein-Barr Virus DNA Quantitative Real-Time PCR test?
While the PCR test is highly specific for EBV DNA, false positives can occur due to sample contamination. False negatives might happen if the viral load is too low to detect or due to issues in sample handling or processing. It's essential always to interpret the results in the context of clinical and other laboratory findings.
Is the Epstein-Barr Virus DNA Quantitative Real-Time PCR test the only test used to diagnose EBV infections?
No, while the PCR test is useful for detecting and quantifying EBV DNA, other tests like the EBV antibody test can be used to diagnose past or recent EBV infections. The choice of test often depends on the clinical scenario and the information sought.
We advise having your results reviewed by a licensed medical healthcare professional for proper interpretation of your results.